Background: Heparan sulfate (HS) attenuates the inflammatory response and improves diabetic wound healing in rats. However, the specific mechanisms by which HS suppresses inflammation are not clear. Given that NLR family pyrin domain containing 3 (NLRP3) is a major receptor involved in innate immune regulation, the aim of the present study was to elucidate the effects of HS on NLRP3 and proinflammatory cytokines in diabetic wounds. Methods: Full-thickness wounds were created on the back of diabetic rats. The experimental group received HS treatment (1 mg/kg, i.m., on Days 0 and 7), whereas the control group received vehicle (0.1% dimethylsulfoxide in 0.9% NaCl). Expression of NLRP3 and its downstream effector molecules, namely cleaved interleukin (IL)-1β, IL-18, tumor necrosis factor (TNF)-α, apoptosisassociated speck-like protein containing a caspase recruitment domain (ASC), proteinase inhibitor 9, and caspase-12, in the wound tissues was examined. Results: Treatment with HS accelerated wound healing in diabetic rats. Rats treated with HS exhibited decreased activation of cleaved IL-1β, IL-18, and TNF-α, as well as decreased expression of NLRP3 and ASC. In addition, HS increased levels of proteinase inhibitor 9 and caspase-12. Conclusions: Heparan sulfate inhibits inflammation and improves wound healing by downregulating the NLRP3 inflammasome and cleaved IL-1β during the wound healing process in diabetic rats.
Introduction
Tissue repair involves overlapping phases of hemostasis, inflammation proliferation, and remodeling. 1 During the normal wound healing process, the inflammatory phase begins at the time of tissue injury and lasts for 10 days. Meanwhile, growth factors released by platelets induce chemotaxis of an array of inflammatory cells, like macrophages, at the wound site to remove bacteria and necrotic tissue. 2 This inflammatory stage should be short, perfectly controlled, and self-resolving. In contrast, a prolonged inflammatory phase may result in permanent residence of inflammatory cells in the wound microenvironment, which may consequently abrogate normal wound healing and transform the wound into a non-healing chronic ulcer. 3 It has been shown that diabetes mellitus can cause prolonged inflammatory reactions and non-healing chronic ulcers. 4 Diabetes can affect multiple cells and molecular effectors and disrupt each phase of the healing progression, resulting in sustained inflammation. 5 Wound healing is associated with dynamic interactions between extracellular matrix (ECM) and growth factors. 6 Heparin sulfate (HS) glycosaminoglycan plays an important role in maintaining the ECM, which is constituted of a network of scaffold proteins. Heparan sulfate is a structural element of tissue scaffold and regulates the activities of locally synthesized proteolytic enzymes, morphogens, chemokines, and growth factors. 7, 8 However, HS is degraded by local matrix metalloproteases and serine proteases. 9 In this process, the balanced interplay of HS is disturbed during the early phase of diabetic wound healing. It has been shown that HS can improve wound healing by attenuating the inflammatory reaction in diabetic rats. 10 However, the specific mechanisms by which HS suppresses inflammation are still not clear.
Inflammasomes are multiprotein oligomers. They respond to inflammatory reactions and initiate an intracellular inflammatory cascade, increasing the cleavage of inactive interleukin (IL)-1β into its active form. 11 The NLR family pyrin domain containing 3 (NLRP3) inflammasome is one of the largest cytosolic inflammasomes and consists of a non-obese diabetic (NOD)-like receptor NLRP3, a procaspase-1, and an adapter protein, namely apoptosisassociated speck-like protein containing a caspase recruitment domain (ASC). The NLRP3 inflammasome is a key regulatory pathway in the inflammatory response in wounds in diabetic mice. 12 During diabetes mellitus, increased accumulation of damage-associated molecular pattern molecule (DAMP) serves to activate the NLRP3 inflammasome, giving rise to inflammasome assembly, which further causes insulin resistance and organ dysfunction. 13 Therefore, in the present study we assessed the possible molecular mechanism by which HS regulates NLRP-3 inflammasome activation and its anti-inflammatory effects.
Methods

Animals
Forty healthy male Sprague-Dawley rats (150-200 g, 8 weeks old) were provided by the Animal Breeding Center in Shanghai Jiao-Tong University Affiliated Sixth People's Hospital (Shanghai, China). All experimental procedures were performed in accordance with the Principles of Laboratory Animal Care (https://www. nap.edu/read/12910/chapter/3#11, accessed 8 December 2017). To create the diabetes model, rats were injected with streptozotocin (STZ; 55 mg/kg, i.p.; SigmaAldrich, St Louis, MO, USA) dissolved in sodium citrate buffer (pH 4.5). Blood was collected from the tail vein and blood glucose levels were determined using a blood glucose monitor (LifeScan, Milpitas, CA, USA). Rats were considered diabetic when the blood glucose levels exceeded 16.7 mmol/L. During the induction of diabetes, one rat died and two rats had persistent glucose levels ≤20 mmol/L. Finally, 37 STZ-injected rats were consistently hyperglycemic. Thirty-six of the STZinjected rats were included in the present study.
To create the diabetic wounds, rats were anesthetized using 3% sodium pentobarbital (1 mL/kg, i.p.). Fullthickness wounds (diameter 2 cm) were created on the back of the rats 1 month after the onset of diabetes. In a pilot experiment, different concentrations of HS (0.1, 0.5, 1, 5 mg/kg; n = 3) were tested to determine the best therapeutic effect. In these pilot studies, 1 and 5 mg/kg HS significantly shorted wound healing time, so the 1 mg/kg dose was chosen for use in the present study. The HS group was injected with 1 mg/kg, i.m., HS (Sigma-Aldrich) on Days 0 and 7 after wounding, so that the HS could infiltrate into the wound site. The control group was injected with 0.1% dimethylsulfoxide (DMSO) in 0.9% NaCl (1: 3, v/v). Wound dressings were changed every day.
Examination of wound closure
To calculate the wound area, the wound margins were traced daily. Photographs of the wounds were taken with a ruler on Days 3, 7 and 14 after wounding. The wound closure rate was calculated as follows formula:
where Area Day 0 is the initial wound area on Day 0 and Area Day n is the wound area on Day n.
Histopathological analysis
Six rats from each group were killed on Days 3, 7 and 14 after wounding. The entire back skin was harvested. Skin tissues were fixed in 10% formalin, sectioned using a microtome, and stained with hematoxylin and eosin (HE; Boster Biological Technology, Wuhan, China) for histological analysis. Slides were examined under a normal light microscope (Olympus, Kanagawa, Japan).
Determination of cleaved IL-1β, IL-18 and TNF-α by ELISA
Levels of cleaved IL-1β, IL-18, and TNF-α in the diabetic rat wounds were determined using commercially available ELISA kits (RA20607, RA20058, and RA20035, respectively; R&D, Minneapolis, MN, USA) according to the manufacturer's instructions. The limits of detection and intra-and interassay coefficients of variation (CV) were as follows: cleaved IL-1β, 35 pg/ mL, 0.47%-3.36% and 0.53%-2.56%, respectively, no cross reactivity; IL-18, 86 pg/mL, 0.44%-1.4%, and 0.33%-1.26%, respectively, no cross reactivity; TNF-α, 91 pg/mL, 0.34%-2.08%, and 0.38%-1.98%, respectively, no cross reactivity. Optical density was recorded using a VICTOR X4 Multilabel Plate Reader (PerkinElmer, Waltham, MA, USA) at 450 nm. Cytokine levels were determined using a standard curve.
Western blotting analysis of NLRP3 expression
Levels of NLRP3 in wound tissues were assayed by western blotting analysis, as described previously. 14 The primary antibody against NLRP3 was purchased from Abcam (1: 1000; AMAB90569; Cambridge, UK). The secondary antibody was obtained from Thermo Scientific (1: 5000; Waltham, MA, USA). The membranebound antibody was visualized using a Phototope-HRP western detection kit (Cell Signaling Technologies, Danvers, MA, USA). Densitometric analysis was performed using a bioimage analysis system (Bio-Profil Celbio, Milan, Italy). The experimental procedures were repeated three times.
Analysis of mRNA expression
Total RNA was extracted from skin tissues using the TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. The RNA (2.0 μg) was reverse transcribed into cDNA in a reaction system containing 10 μL SYBR Green, 0.1 μL each forward primer, 10 pmol/μL reverse primer, and 2 μL cDNA. The polymerase chain reaction (PCR) was conducted in a Veriti Thermal Cycler (Applied Biosystems, Foster City, CA, USA) followed by 30 cycles of 95 C for 45 s, with a final step of 60 s at 60 C annealing steps, with data collection in the last 30 s. The relative amount of ASC, proteinase inhibitor 9 (PI9), and caspase-12 (CASP12) mRNA was normalized against that of glyceraldehyde-3-phosphate dehydrogenase (GAPDH), used as an internal control, and expression calculated using the 2 −ΔΔCt method. The sequences of the primers used in the present study are given in Table 1 . The experimental procedures were repeated three times.
Statistical analysis
All data are expressed as the mean AE SEM. The HSand placebo (control)-treated groups were compared using the one-way analysis of variance (ANOVA) in SPSS 14.0 (SPSS Inc., Chicago, IL, USA). Expression levels of cleaved IL-1β, IL-18, TNF-α, ASC, NLRP3, PI9, and CASP12 in diabetic wounds between the HS and control groups were compared using paired or unpaired Student's t-test. Two-tailed P < 0.05 was considered significant.
Results
Blood glucose and body weight
During the diabetes induction period, mean body weight fell by 12%. Heparan sulfate treatment had no effect on mean blood glucose or body weight (Fig. 1) .
Diabetic wound healing
Representative photographs of the effects of HS treatment on the healing of diabetic wounds on Days 0, 3, 7 and 14 are shown in Fig. 2a . The size of wounds in both the HS and control groups was calculated daily after wounding. The wound closure rate in the HS-treated group was significantly higher than in the control group from Day 6 (Fig. 2b) .
Histopathology
Excessive inflammation is a characteristic feature of diabetes-impaired wound healing. It has been shown that HS can improve diabetic wound healing in rats by reducing neutrophil infiltration. 10 As shown in Fig. 3 , representative HE sections of diabetic wounds show that the inflammatory reaction was significant in both the HS and control groups on Day 0. However, on Days 7 and 14, well-healing wounds with mild inflammation were seen in the HS group, whereas the inflammatory reactions in the control group remained significant (Fig. 3) .
Cytokine levels
Proinflammatory cytokines, particularly cleaved IL-1β, IL-18, and TNF-α, play important roles in mediating wound inflammation. As shown in Fig. 4 , levels of cleaved IL-1β, IL-18, and TNF-α were significantly lower in the HS than control group.
Levels of NLRP3
The NLRP3 inflammasome plays an important role in the pathophysiology of many inflammatory diseases, including insulin resistance and diabetes, 15, 16 and possible mechanisms underlying the anti-inflammatory effects of HS may include its inhibition of the NLRP3 inflammasome. In the present study, increased and sustained activation of the NLRP3 inflammasome was seen in the control group. Western blotting analysis revealed that NLRP3 levels in the HS group were significantly lower than in the control group on Days 3, 7 and 14. However, NLRP3 levels in the HS group were significantly higher on Day 14 than on Day 3 (Fig. 5a,b) .
Expression of PI9, ASC, and CASP12 mRNA
Macrophages isolated from chronic wounds of diabetic patients have downregulated expression of PI9 and CASP12, 17 which may contribute to the switch from a proinflammatory phenotype to a prohealing phenotype. In the present study, HS treatment significantly upregulated PI9 mRNA expression on Day 14 compared with that in the control group (0.175 AE 0.040 vs 0.104 AE 0.033, respectively; P = 0.007; Fig. 5c ). Similarly, CASP12 mRNA was significantly higher in the HS than control group on Day 7 (0.118 AE 0.040 vs 0.058 AE 0.030, respectively; P = 0.015) and on Day 14 (0.175 AE 0.040 vs 0.085 AE 0.035, respectively; P = 0.002; Fig. 5e ). However, ASC mRNA was significantly downregulated in the HS compared with control group on Day 7 (0.043 AE 0.018 vs 0.143 AE 0.030, respectively; P = 0.008) and on Day 14 (0.021 AE 0.012 vs 0.097 AE 0.030, respectively; P = 0.007; Fig. 5d ).
Discussion
The present study focused on the possible molecular mechanism underlying the anti-inflammatory effect of HS treatment. To our knowledge, the present study is the first to clearly demonstrate involvement of HS and the NLRP3 inflammasome, including its downstream cascade, in wound healing in diabetic rats. Furthermore, the present study demonstrates the efficacy of HS in improving the healing of diabetic wounds via reduced activation of the NLRP3 inflammasome.
Excessive inflammation, associated with the prolonged persistence of neutrophil infiltration, is a characteristic feature of diabetes-impaired wound healing, 3 and it has been shown that HS can improve diabetic wound healing in rats by attenuating inflammatory reactions. 10 However, the specific mechanisms by which HS suppresses inflammation remain unclear. It was speculated that HS improves wound healing by reducing neutrophil infiltration and macrophage accumulation. 10 The present study found that HS reduced wound healing time and alleviated inflammation in diabetic rats. These findings are consistent with those reported by Tong et al. 18 Cleaved IL-1β is predominantly produced by neutrophils, monocytes, and macrophages, and is involved in the pathogenesis of various inflammatory diseases, such as diabetes. 19 Proinflammatory cytokines, particularly cleaved IL-1β and IL-18, play important roles in wound inflammation. Antagonists against cleaved IL-1β or IL-18 have been used to treat gout and arthritis. 20, 21 Inhibition of IL-18 has been shown to reduce neutrophil infiltration following injury. 22 In addition, diabetic wounds were more susceptible to hyperinflammatory responses. Tumor necrosis factor-α is a representative proinflammatory cytokine, and high levels of TNF-α can amplify and prolong inflammatory reactions. 23, 24 Accordingly, in the present study, HS significantly reduced levels of cleaved IL-1β, IL-18, and TNF-α in diabetic rats.
The NLRP3 inflammasome plays an important role in the pathophysiology of many inflammatory diseases, including insulin resistance and diabetes. 15, 16 Possible mechanisms of the anti-inflammatory effects of HS may include its inhibition of the activity of the NLRP3 inflammasome. The inflammasome is a multiprotein complex that plays an important role in host immune activation in response to harmful stimuli. 25 It has been shown that the NLRP3 inflammasome mediates the downstream inflammatory events of glucotoxicity and the continuous proinflammatory status in diabetes. 13 Reducing levels of the NLRP3 inflammasome is one of the mechanisms of diabetic wound healing during glucotoxicity. In the present study, HS treatment decreased levels of NLRP3 and ASC in rats. After activation signaling, NLRP3 monomers are considered to oligomerize and ASC is recruited through pyrin domain interactions. 26 In addition, HS increased levels of CASP12 and PI9 in the present study; CASP12 is thought to inhibit inflammasome activity by preventing inflammasome assembly, 27, 28 whereas PI9 directly inhibits caspase-1.
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Caspase-12 and PI9 are upregulated in macrophages after switching from a proinflammatory to a prohealing phenotype. 27 Macrophages isolated from chronic wounds of diabetic patients show low levels of CASP12 and PI9. 17 A better understanding of the regulation of Expression of NLRP3 was normalized against that of glyceraldehyde-3-phosphate dehydrogenase (GAPDH), whereas mRNA expression of PI9, ASC, and CASP12 is shown relative to GAPDH. Data are the mean AE SEM. *P < 0.05 compared with the control group; † P < 0.05 compared with the HS group on Day 3; ‡ P < 0.05 compared with the HS group on Day 7.
these inflammasome cytokines could lead to the development of targets to limit the activity of the inflammasome in inflammatory pathologies. The present study demonstrated that HS decreased NLRP3 activation and ASC levels, and increased cleavage of CASP12 and PI9, which, in turn, led to the formation of mature IL-1β and IL-18 from their precursors. Consequently, the production of inflammatory cytokines in diabetic wounds was decreased, neutrophil infiltration was reduced, and the progressive diabetic wound environment was ameliorated. Finally, the time to wound healing was shortened.
In conclusion, the results of the present study demonstrate for the first time that the anti-inflammatory effect of HS is associated with downregulation of the activation of the NLRP3 inflammasome, which inhibited activation of the inflammatory cascade during diabetic wound healing. However, the present study has some limitations. First, the experiments were performed on laboratory animals; however, cell experiments are planned in the future. Finally, a randomized clinical trial may be needed to confirm the results of the present study.
